ScanCell’s Skin Cancer Vaccine Shows Phase 2 Promise, but Only One Candidate Moves Forward
ScanCell, a biotech firm focused on immunotherapies, announced promising results from Phase 2 clinical trials for its skin cancer vaccines, but only one of its two candidates will advance to…